Direct diagnosis is superior to risk factor prediction tools for management of vessel wall disease by Divani, A A et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Direct diagnosis is superior to risk factor prediction tools for management of
vessel wall disease
Divani, A A; Luft, A R; Flaherty, J D; Rao, G H R
Abstract: Unspecified
DOI: 10.3389/fneur.2012.00036
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-67126
Published Version
Originally published at:
Divani, A A; Luft, A R; Flaherty, J D; Rao, G H R (2012). Direct diagnosis is superior to risk
factor prediction tools for management of vessel wall disease. Frontiers in Neurology, 3:36. DOI:
10.3389/fneur.2012.00036
Direct diagnosis is superior to risk factor prediction tools for 
management of vessel wall disease
Afshin A. Divani1,2*, Andreas R. Luft 3, James D. Flaherty 4 and Gundu H. R. Rao5
1 Department of Neurology, University of Minnesota, Minneapolis, MN, USA
2 Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA
3 Department of Neurology, University of Zurich, Zurich, Switzerland
4 Division of Cardiology, Department of Medicine, Northwestern University, Chicago, IL, USA
5 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
*Correspondence: divani@umn.edu
Diseases of the arteries cause more mor-
bidity and mortality than most other non-
communicable diseases, including cancer. 
Atherosclerosis, the most prevalent vas-
culopathy, leads to myocardial infarction, 
stroke, or occlusions of peripheral arteries, 
but also causes slowly progressive disorders 
such as subcortical vascular encephalopa-
thy or chronic kidney disease. A patient not 
presenting with a vascular event is typically 
assessed for atherosclerosis indirectly by 
cardiovascular risk factor prediction tools, 
rather than directly by imaging of the ves-
sel wall for primary prevention (Goldstein 
et al., 2011). Only after a clinical event 
such as a stroke, the arteries are imaged by 
ultrasound, computed tomography (CT), 
magnetic resonance imaging (MRI), digital 
subtraction angiography (DSA). We suggest 
that, in primary prevention, a diagnostic 
paradigm that includes vascular imag-
ing studies yields greater clinical benefits 
than assessing risk factors alone. Such an 
approach would provide an opportunity for 
customized therapy.
The Framingham study provided evi-
dence supporting a causative role of risk 
factors, such as hypertension, diabetes, 
and altered blood lipid profiles, for vascu-
lar events (Dawber et al., 1951). Based on 
these results, management strategies for the 
control of these risk factors were developed 
(Dawber et al., 1951; Bitton and Gaziano, 
2010). Risk monitoring tools currently 
available include the Framingham risk score 
(FRS) and the University of Minnesota 10 
Point Risk Scoring System (Cohn et al., 
2003). Imaging techniques, such as meas-
uring intimal medium thickness (IMT) in 
carotid ultrasound, assessing coronary cal-
cium content by CT, vessel volume meas-
urements by MRI, and pulse wave velocity 
(PWV) index for monitoring arterial com-
pliance are available to identify generalized 
(systemic) atherosclerosis and can be used 
to follow the progression of the disease (Rao 
and Sriram, 2010). Recent studies utilizing 
CT and MRI have demonstrated that the 
FRS may fail to identify up to 30% of indi-
viduals with atherosclerotic vascular disease 
(Johnson and Dowe, 2010).
One emerging technique to identify and 
track the progression (or regression) of 
carotid plaques is 3D ultrasound (Spence 
et al., 2002). Studies from the Robarts 
Research Institute in London, Ontario, have 
demonstrated that similar to total IMT 
measurements, total plaque volume (TPV), 
or total plaque area (TPA) measurements 
can be used to monitor the progression of 
atherosclerosis (Landry et al., 2004, 2005). 
Furthermore, these studies have demon-
strated that aggressive lipid lowering using 
drugs such as atorvastatin can reduce the 
TPV significantly within 3 months. This 
technique has been shown to be sensitive 
enough to monitor diet or drug-induced 
changes in TPV. However, 3D ultrasound 
studies have also demonstrated that TPV 
may increase even after significant lowering 
of lipid levels, suggesting the need for addi-
tional therapies, such as antihypertensive 
therapy that has been shown to reduce plaque 
volume (Nissen et al., 2004). Although serial 
IMT measurement is more established, it is 
insensitive to drug-induced alterations in the 
TPV or TPA. Further studies of characteri-
zation of the morphology and composition 
of the plaque may enhance risk prediction.
For decades, the FRS has been considered 
the gold standard for cardiovascular risk 
prediction. Cohn et al. (2003) demonstrated 
that the University of Minnesota 10 Point 
Scale, which combines laboratory and physi-
ologic measurements, is superior to the FRS 
at predicting clinical events over a 6-year 
follow-up. However, newer  techniques 
Table 1 | Risk factors for modeling versus disease identification strategy.
Risk factor identification Disease identification
PROS
Provides estimate of risk for cardiovascular 
events
Provides evidence for presence or absence of vascular 
disease
Usually simple and reproducible Individuals without vascular disease not subjected to 
unnecessary treatment
Lower upfront cost Individuals with vascular disease receive necessary 
treatment
Risk can be followed serially over time Disease progression or regression can be followed serially 
over time
CONS
Individuals without vascular disease may 
receive unnecessary treatment*
Requires imaging interpretation
Individuals with vascular disease may not 
receive necessary treatment
Higher upfront and follow-up costs
*This does not mean that vascular risk factors should not be treated in the absence of vascular disease. It 
means that the intensity of treatment (e.g., treatment goals of cholesterol) may be unnecessarily high in 
some patients.
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such as IMT and cardiac calcium scoring 
may replace indirect risk scoring systems. 
Recent 3D ultrasound techniques can moni-
tor plaque volume, plaque progression, and 
plaque regression (Fenster et al., 2004, 2006; 
Landry et al., 2004, 2005, 2007; Ainsworth 
et al., 2005). Further studies on the mor-
phology and composition of plaques will 
provide the ability to predict the nature of 
the plaque such as stability or vulnerability. 
There is an urgent need for the development 
of high-resolution, super-sensitive ultra-
sound systems that can monitor the athero-
sclerotic plaque in regional vascular beds of 
both small- and medium-sized vessels, so 
that the progression of the disease as well as 
the effectiveness of management of the dis-
ease with appropriate treatment modalities 
can be followed. We believe that the use of 
modern imaging techniques – especially of 
predilection sites of atherosclerosis, i.e., the 
carotids and the coronaries – as screening 
and monitoring tools in the primary pre-
vention of vascular disease in addition to 
risk factor prediction could form the basis 
for a paradigm shift in vascular medicine 
from diagnosing risk factors to identifying 
the individual disease burden (see Table 1). 
However, such new techniques need to show 
their predictive value for vascular events 
and progression of chronic vascular disease 
before they can be uniformly recommended.
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